Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00238303 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

DRUG: vorinostat
PROCEDURE: conventional surgery

Sponsor

National Cancer Institute (NCI)